Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
Record 3 of 6
  Previous Record Previous Item Next Item Next Record
 
COMPUTER FILE
Title Guidance for industry : changes to an approved application : biological products, human blood and blood components intended for transfusion or for further manufacture.
Imprint Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2001]

LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4802:B 52/4    ONLINE  
Subject Blood -- Transfusion -- Government policy -- United States.
Blood products -- United States -- Evaluation -- Government policy.
Alt Name Center for Biologics Evaluation and Research (U.S.)
Add Title Changes to an approved application
Biological products, human blood and blood components intended for transfusion or for further manufacture
LOCATION CALL # STATUS MESSAGE
 ONLINE GOVERNMENT PUBLICATION  HE 20.4802:B 52/4    ONLINE  
Subject Blood -- Transfusion -- Government policy -- United States.
Blood products -- United States -- Evaluation -- Government policy.
Alt Name Center for Biologics Evaluation and Research (U.S.)
Add Title Changes to an approved application
Biological products, human blood and blood components intended for transfusion or for further manufacture
Description i, 30 pages : digital, PDF file
monochrome rdacc
System Details Mode of access: Internet at the FDA CBER web site. Address as of 5/28/09: http://www.fda.gov/cber/gdlns/bldchanges.pdf ; current access is available via PURL.
Note Title from PDF title page (viewed on May 28, 2009).
"July 2001".
Bibliography Note Includes bibliographical references (p. 25-26).
OCLC # 355680178


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team